한글목차

에스트로겐 차단제 시장은 2025년에는 170억 4,000만 달러, 2032년에는 264억 8,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 연평균 성장률(CAGR)은 6.5%를 보일 것으로 예측됩니다.

에스트로겐 차단제는 체내 에스트로겐의 작용을 억제하기 위해 호르몬 보충 요법(HRT)의 일환으로 FTM(여성에서 남성으로) 환자에게 사용되는 의약품입니다. 또한 남성의 제 2차 성징의 개발을 촉진하는 효과도 있습니다.

에스트로겐 차단제는 정제 또는 주사의 형태로 복용 할 수 있습니다. 이들은 일반적으로 더 큰 HRT 치료 계획의 일부로 처방되며 일반적으로 복용자의 내약성은 양호합니다.

시장 역학

에스트로겐 차단제는 다낭성 난소 증후군(PCOS), 자궁내막증, 유방암 등의 호르몬 관련 질환의 치료에 주로 사용되고 있습니다.

예를 들어, 2023년 6월 28일 세계보건기구(WHO)가 발표한 보고서에 따르면, 다낭성 난소 증후군(PCOS)은 공중 보건에 중요한 문제이며 생식 연령의 여성에 영향을 미칩니다. 가장 흔한 호르몬 장애 중 하나로 간주되며,이 질병은 매년 생식 연령의 여성의 8-13%가 영향을 받는 것으로 추정되며 최대 70%의 사례가 진단되지 않았습니다.

반면에 다른 약물과 마찬가지로 에스트로겐 차단제에는 잠재적 위험과 부작용이 있습니다. 장기간 사용하면 심혈관계 문제와 골량 감소의 위험이 높아질 수 있습니다.

이 보고서의 주요 특징

• 당 보고서는 세계의 에스트로겐 차단제 시장을 상세하게 분석했으며, 2024년을 기준연도로 한 예측 기간(2025-2032년) 시장 규모 및 CAGR을 제공합니다.
• 또한 각 부문의 잠재적인 수익 기회를 밝혀 이 시장의 매력적인 투자 제안의 매트릭스에 대해 설명하고 있습니다.
• 또, 시장 성장 촉진요인 및 억제요인이나 기회, 신제품의 상시나 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
• 세계의 에스트로겐 차단제 시장에 있어서의 주요 기업 프로파일을, 기업 개요, 제품 포트폴리오, 주요한 하이라이트, 재무 실적, 전략 등의 이하의 파라미터에 근거해 제공합니다.
• 본 보고서의 통찰을 이용해, 마케팅 담당자나 기업의 경영진이, 장래의 제품 발매, 제휴, 시장 확대, 마케팅 전술에 관한, 충분한 정보에 근거한 의사 결정을 내릴 수 있습니다.
• 「세계의 에스트로겐 차단제 시장」보고서는 투자자, 공급자, 제품 제조업체, 유통업체, 신규 참가자, 재무 애널리스트 등, 이 업계의 다양한 이해 관계자에 대응하고 있습니다.
• 이해관계자는 세계의 에스트로겐 차단제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학·규제·동향의 분석

• 시장 역학
  • 성장 촉진요인
    • 호르몬 관련 질환의 유병률 증가
  • 억제요인
    • 부작용과 안전성에 대한 우려
  • 기회
    • 적응증의 확대
• 영향 분석
• 주요 하이라이트
• 규제 시나리오
• 제품 출시/승인
• PEST 분석
• Porter's Five Forces 분석
• 기업 합병·인수(M&A) 시나리오

제4장 세계의 에스트로겐 차단제 시장 : 신형 코로나 바이러스 감염증(COVID-19) 팬데믹의 영향

• COVID-19의 역학
• 공급측과 수요측의 분석
• 경제에 미치는 영향

제5장 세계의 에스트로겐 차단제 시장 : 제품 유형별(2020-2032년)

• 선택적 에스트로겐 수용체 변형제(SERM)
• 아로마타제 억제제
• 에스트로겐 수용체 분해제(ERD)
• 기타

제6장 세계의 에스트로겐 차단제 시장 : 용도별(2020-2032년)

• 유방암 치료
• 호르몬 보충 요법(HRT)
• 불임치료
• 폐경 후 골다공증
• 기타

제7장 세계의 에스트로겐 차단제 시장 : 유통 채널별(2020-2032년)

• 병원 약국
• 소매 약국
• 온라인 약국

제8장 세계의 에스트로겐 차단제 시장 : 지역별(2020-2032년)

• 북미
  • 미국
  • 캐나다
• 유럽
  • 독일
  • 영국
  • 스페인
  • 프랑스
  • 이탈리아
  • 러시아
  • 기타 유럽
• 아시아태평양
  • 중국
  • 인도
  • 일본
  • 호주
  • 한국
  • ASEAN
  • 기타 아시아태평양
• 라틴아메리카
  • 브라질
  • 아르헨티나
  • 멕시코
  • 기타 라틴아메리카
• 중동
  • GCC 국가
  • 이스라엘
  • 기타 중동
• 아프리카
  • 남아프리카
  • 북아프리카
  • 중앙 아프리카

제9장 경쟁 구도

• Pfizer Inc.
• Novartis AG
• AstraZeneca PLC
• Eli Lilly and Company
• Merck & Co., Inc.
• Bristol Myers Squibb Company
• Sanofi SA
• AbbVie Inc.
• GlaxoSmithKline plc
• Olema Pharmaceuticals, Inc.
• Scorpion Therapeutics, Inc.
• Allorion Therapeutics Inc
• Carrick Therapeutics Limited
• Criterium, Inc.
• Hoffmann-La Roche

제10장 섹션

• 분석 방법
• 출판사에 대해

영문목차

Estrogen Blockers Market is estimated to be valued at USD 17.04 Bn in 2025 and is expected to reach USD 26.48 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.5% from 2025 to 2032.

Estrogen blockers are medicines that are used by FTM (female to male) individuals as part of their hormone replacement therapy (HRT) to suppress the effects of estrogen in the body. They can also help to promote the development of male secondary sexual characteristics. There are many different types of estrogen blockers available, and some are more effective than others.

Estrogen blockers can be taken in the form of tablets or injections. They are usually prescribed as part of a larger HRT treatment plan and are generally well tolerated by individuals who take them. For the most part, a hospital stay is not required when taking these medications, and they can often be given at home.

Market Dynamics

Estrogen blockers are largely used to treat hormone-related diseases like polycystic ovary syndrome (PCOS), endometriosis, and breast cancer. The demand for estrogen blockers rises as the prevalence of these illnesses rises internationally, fueling market expansion.

For instance, on June 28, 2023, according to a report published by the World Health Organization, reported that polycystic ovary syndrome (PCOS) is a significant public health problem and considered as one of the commonest hormonal disturbances affecting women of reproductive age. The condition affects an estimated 8-13% of women of reproductive age every year, and up to 70% of cases are undiagnosed.

On the other hand, like any drug, estrogen blockers have potential risks and adverse effects. Hot flashes, mood swings, joint discomfort, and increases in cholesterol levels are examples of typical side effects. In some circumstances, long-term use of estrogen blockers may raise the risk of cardiovascular issues and bone loss. Patients' compliance with and acceptance of estrogen blockers may be impacted by safety worries and possible side effects.

Key features of the study:

• This report provides in-depth analysis of the global estrogen blockers market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global estrogen blockers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Pfizer Inc., Novartis AG, AstraZeneca PLC, Eli Lilly and Company, Merck & Co., Inc., Bristol Myers Squibb Company, Sanofi S.A., AbbVie Inc., GlaxoSmithKline plc, Olema Pharmaceuticals, Inc., Scorpion Therapeutics, Inc., Allorion Therapeutics Inc, Carrick Therapeutics Limited, Criterium, Inc. and Hoffmann-La Roche
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global estrogen blockers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global estrogen blockers market

Detailed Segmentation:

• Global Estrogen Blockers Market, By Product Type:
  • Selective Estrogen Receptor Modulators (SERMs)
  • Aromatase Inhibitors
  • Estrogen Receptor Downregulators (ERDs)
  • Others
• Global Estrogen Blockers Market, By Application:
  • Breast Cancer Treatment
  • Hormone Replacement Therapy (HRT)
  • Infertility Treatment
  • Post-Menopausal Osteoporosis
  • Others
• Global Estrogen Blockers Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Estrogen Blockers Market, By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
• Company Profiles
  • Pfizer Inc.
  • Novartis AG
  • AstraZeneca PLC
  • Eli Lilly and Company
  • Merck & Co., Inc.
  • Bristol Myers Squibb Company
  • Sanofi S.A.
  • AbbVie Inc.
  • GlaxoSmithKline plc
  • Olema Pharmaceuticals, Inc.
  • Scorpion Therapeutics, Inc.
  • Allorion Therapeutics Inc
  • Carrick Therapeutics Limited
  • Criterium, Inc.
  • F.Hoffmann-La Roche

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Estrogen Blockers, By Product Type
  • Market Estrogen Blockers, By Application
  • Market Estrogen Blockers, By Distribution Channel
  • Market Estrogen Blockers, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
• Increasing Prevalence of Hormone-related Disorders
  • Restraints
• Side Effects and Safety Concerns
  • Opportunities
• Expansion of Indications
• Impact Analysis
• Key Highlights
• Regulatory Scenario
• Product launch/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario

4. Global Estrogen Blockers Market - Impact of Coronavirus (COVID-19) Pandemic

• COVID-19 Epidemiology
• Supply Side and Demand Side Analysis
• Economic Impact

5. Global Estrogen Blockers Market, By Product Type, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Selective Estrogen Receptor Modulators (SERMs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Aromatase Inhibitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Estrogen Receptor Downregulators (ERDs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Estrogen Blockers Market, By Application, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Breast Cancer Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Hormone Replacement Therapy (HRT)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Infertility Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Post-Menopausal Osteoporosis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Others
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Estrogen Blockers Market, By Distribution Channel, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Estrogen Blockers Market, By Region, 2020-2032, (US$ Bn)

• Introduction
  • Market Share Analysis, By Country, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Country 2021 -2032
  • Country Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • U.S.
    • Canada
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032,(US$ Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

• Pfizer Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novartis AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AstraZeneca PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Eli Lilly and Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Merck & Co., Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Bristol Myers Squibb Company
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Sanofi S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• AbbVie Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• GlaxoSmithKline plc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Olema Pharmaceuticals, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Scorpion Therapeutics, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Allorion Therapeutics Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Carrick Therapeutics Limited
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Criterium, Inc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Hoffmann-La Roche
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
• Analyst Views

10. Section

• Research Methodology
• About us